ZA200503240B - Methods of using and compositions comprising immunodulatory compounds for treatment, modification and management of pain - Google Patents

Methods of using and compositions comprising immunodulatory compounds for treatment, modification and management of pain

Info

Publication number
ZA200503240B
ZA200503240B ZA200503240A ZA200503240A ZA200503240B ZA 200503240 B ZA200503240 B ZA 200503240B ZA 200503240 A ZA200503240 A ZA 200503240A ZA 200503240 A ZA200503240 A ZA 200503240A ZA 200503240 B ZA200503240 B ZA 200503240B
Authority
ZA
South Africa
Prior art keywords
immunodulatory
pain
compositions
management
compounds
Prior art date
Application number
ZA200503240A
Other languages
English (en)
Inventor
Jerome B Zeldis
Faleck Herbert
Donald C Manning
Original Assignee
Gelgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelgene Corp filed Critical Gelgene Corp
Publication of ZA200503240B publication Critical patent/ZA200503240B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200503240A 2002-10-24 2003-10-24 Methods of using and compositions comprising immunodulatory compounds for treatment, modification and management of pain ZA200503240B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42100302P 2002-10-24 2002-10-24

Publications (1)

Publication Number Publication Date
ZA200503240B true ZA200503240B (en) 2007-11-28

Family

ID=32176661

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200503240A ZA200503240B (en) 2002-10-24 2003-10-24 Methods of using and compositions comprising immunodulatory compounds for treatment, modification and management of pain

Country Status (13)

Country Link
EP (1) EP1556044A2 (fr)
JP (1) JP2006507284A (fr)
KR (1) KR20050057672A (fr)
CN (2) CN101108185A (fr)
AU (1) AU2003286663B2 (fr)
BR (1) BR0315609A (fr)
CA (1) CA2503536A1 (fr)
HK (1) HK1088225A1 (fr)
MX (1) MXPA05004182A (fr)
NZ (1) NZ540028A (fr)
TW (1) TW200503683A (fr)
WO (1) WO2004037199A2 (fr)
ZA (1) ZA200503240B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228769B1 (en) 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
US20050203142A1 (en) * 2002-10-24 2005-09-15 Zeldis Jerome B. Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
US7563810B2 (en) * 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US20050143344A1 (en) * 2003-12-30 2005-06-30 Zeldis Jerome B. Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases
US20050222209A1 (en) * 2004-04-01 2005-10-06 Zeldis Jerome B Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
CA2603926A1 (fr) * 2005-04-08 2006-10-12 Neuromed Pharmaceuticals Ltd. Therapie de combinaison qui comprend un agent bloquant les canaux calciques de type n pour le soulagement de la douleur
US20070066512A1 (en) * 2005-09-12 2007-03-22 Dominique Verhelle Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
JP4382735B2 (ja) * 2005-10-06 2009-12-16 独立行政法人科学技術振興機構 神経因性疼痛治療剤
KR20090014393A (ko) * 2006-05-26 2009-02-10 셀진 코포레이션 조합 요법에서 면역조절 화합물을 사용하는 방법 및 조성물
US20110184025A1 (en) * 2006-10-19 2011-07-28 Hensel Jennifer L Methods and Compositions Using Immunomodulatory Compounds for the Treatment and Management of Spirochete and Other Obligate Intracellular Bacterial Diseases
CN101696205B (zh) 2009-11-02 2011-10-19 南京卡文迪许生物工程技术有限公司 3-(取代二氢异吲哚-2-基)-2,6-哌啶二酮多晶型物和药用组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215114A (en) * 1976-11-12 1980-07-29 The Upjohn Company Analgesic N-[2-(furyl-methylamino and 2-thienylmethylamino)cycloaliphatic]be
HU228769B1 (en) * 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
DE69740140D1 (de) * 1996-07-24 2011-04-14 Celgene Corp Substituierte 2-(2,6-Dioxopiperidin-3-yl)-phthalimide und Oxoisoindoline und Verfahren zur Verringerung der TNF-Alpha-Stufen
US6281230B1 (en) * 1996-07-24 2001-08-28 Celgene Corporation Isoindolines, method of use, and pharmaceutical compositions
US5955476A (en) * 1997-11-18 1999-09-21 Celgene Corporation Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
US20030045552A1 (en) * 2000-12-27 2003-03-06 Robarge Michael J. Isoindole-imide compounds, compositions, and uses thereof
SE0101256D0 (sv) * 2001-04-06 2001-04-06 A & Science Invest Ab Treatment of low back pain

Also Published As

Publication number Publication date
EP1556044A2 (fr) 2005-07-27
AU2003286663B2 (en) 2009-08-13
CA2503536A1 (fr) 2004-05-06
KR20050057672A (ko) 2005-06-16
AU2003286663A1 (en) 2004-05-13
NZ540028A (en) 2009-07-31
HK1088225A1 (en) 2006-11-03
CN101108185A (zh) 2008-01-23
WO2004037199A3 (fr) 2004-12-23
CN1732000A (zh) 2006-02-08
MXPA05004182A (es) 2005-06-08
BR0315609A (pt) 2005-08-23
JP2006507284A (ja) 2006-03-02
WO2004037199A2 (fr) 2004-05-06
TW200503683A (en) 2005-02-01
CN1326522C (zh) 2007-07-18

Similar Documents

Publication Publication Date Title
EP1680111A4 (fr) Procedes d'utilisation et compositions comprenant des composes immunomodulaires pour traiter, modifier et gerer la douleur
EP1567157A4 (fr) Methodes d'utilisation et compositions recourant a des composes immunomodulatoires pour le traitement et la gestion de syndromes myeloproliferatifs
EP1567158A4 (fr) Procedes et compositions utilisant des composes immunomodulateurs pour traiter et maitriser des cancers et d'autres maladies
HRP20040665B1 (en) Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
AU2003257937A8 (en) Methods and compositions for treatment of dermal conditions
IL209352A0 (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
EP1613266A4 (fr) Methodes de traitement de la douleur et compositions associees
AU2003287443A8 (en) Compositions and methods for pain reduction
ZA200503240B (en) Methods of using and compositions comprising immunodulatory compounds for treatment, modification and management of pain
AU2003211009A8 (en) Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
EP1551388A4 (fr) Composes utiles dans le traitement du cancer, compositions et procedes correspondants
GB0211295D0 (en) Treatment of pain
EP1680132A4 (fr) Traitement, modification et gestion des fibromyalgies avec des compositions a base de thalidomide, et procedes correspondants
IL166062A0 (en) Compositions and methods for therapeutic treatment
AU2003275433A8 (en) Compositions and methods for treating pain
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
GB0208897D0 (en) New method of treatment
GB0217493D0 (en) Novel methods of treatment
AU2003225563A8 (en) Compositions and methods for treatment of osteoarthritis
GB0221712D0 (en) Methods of treatment
AU2003202255A8 (en) Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
AU2003272327A8 (en) Methods of bone healing
GB0207091D0 (en) Method of treatment
IL151799A0 (en) Composition for treatment of onychomycosis